SUPPLEMENT NO. 3 TO TRANSACTION AGREEMENTSSupplement to Transaction Agreements • December 18th, 2020 • Lexicon Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Supplement No. 3 to Transaction Agreements (this “Supplement”) is entered into as of December 16, 2020 by and among Invus, L.P., a Bermuda limited partnership (“Invus, L.P.”), Invus C.V., a Netherlands limited partnership (“Invus C.V.”), and Lexicon Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Securities Purchase Agreement (as defined below).
